Answers are grounded in this paper and cite their sources.
Clozapine is the gold-standard antipsychotic agent for treatment-resistant schizophrenia. Yet with all its clinical efficacy, there are numerous adverse effects associated with clozapine. Although many, such as leucopenia and agranulocytosis, are well established, there is little published material on the drug's rare adverse effects. Among these, very little is known about clozapine-induced interstitial lung disease. Here we present such a case. We focus on its clinical aspects and discuss its relationship to the extant literature.
No takes yet. Share an insight, caveat, or question.
Can et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: